P1 · PANEL / ROI / AXIS GROUND TRUTH
原 EXE 对齐基准真值复核
所有保存均写入追加式审计事件;旧标注、旧比较和旧提取结果不会被删除或覆盖。
gray_or_same_color
pending
PMID 40601896
Geneva Homologous Recombination Deficiency Test Is Predictive of Survival Benefit From Olaparib and Bevacizumab Maintenance in Ovarian Cancer.
figA1 · Panel B · OS
Kaplan-Meier OS curves for the HRD-positive subpopulation, according to the Geneva HRD test, with respect to the BRCA mutation status (given by the Myriad test). (A) BRCA mutated and (B) BRCA wild-type. HR, hazard ratio; HRD, homologous recombination deficiency; OS, overall survival.坐标框复核
洋红 = 当前 Linux 候选;绿色 = 已保存人工真值。没有绿色框表示仍未形成真值。
当前候选 {'x0': 552, 'y0': 177, 'x1': 1871, 'y1': 899}
人工真值 {'x0': 552, 'x1': 1871, 'y0': 177, 'y1': 899}
查看候选 OCR 与警告(只能作种子,不能自证真值)
{
"complete": true,
"engine": "RapidOCR",
"plot_bottom": 898,
"plot_left": 552,
"plot_right": 1870,
"plot_top": 177,
"warnings": [],
"x_axis_y": 898,
"x_confidence": 0.758,
"x_detected": true,
"x_max": 78,
"x_min": 6,
"x_ticks": [
{
"box": [
[
532.0,
980.0
],
[
571.0,
980.0
],
[
571.0,
1021.0
],
[
532.0,
1021.0
]
],
"confidence": 0.9993700385093689,
"pixel": 551.5,
"text": "6",
"value": 6.0
},
{
"box": [
[
1844.0,
979.0
],
[
1896.0,
979.0
],
[
1896.0,
1023.0
],
[
1844.0,
1023.0
]
],
"confidence": 0.9989802241325378,
"pixel": 1870.0,
"text": "78",
"value": 78.0
}
],
"y_axis_x": 442,
"y_confidence": 1.0,
"y_detected": true,
"y_max": 1,
"y_min": 0,
"y_ticks": [
{
"box": [
[
218.0,
150.0
],
[
335.0,
150.0
],
[
335.0,
203.0
],
[
218.0,
203.0
]
],
"confidence": 0.9999321401119232,
"pixel": 176.5,
"text": "1.00",
"value": 1.0
},
{
"box": [
[
213.0,
331.0
],
[
335.0,
331.0
],
[
335.0,
384.0
],
[
213.0,
384.0
]
],
"confidence": 0.9999692440032959,
"pixel": 357.5,
"text": "0.75",
"value": 0.75
},
{
"box": [
[
215.0,
511.0
],
[
336.0,
511.0
],
[
336.0,
564.0
],
[
215.0,
564.0
]
],
"confidence": 0.99997478723526,
"pixel": 537.5,
"text": "0.50",
"value": 0.5
},
{
"box": [
[
215.0,
690.0
],
[
335.0,
690.0
],
[
335.0,
744.0
],
[
215.0,
744.0
]
],
"confidence": 0.9999643862247467,
"pixel": 717.0,
"text": "0.25",
"value": 0.25
},
{
"box": [
[
213.0,
871.0
],
[
333.0,
871.0
],
[
333.0,
925.0
],
[
213.0,
925.0
]
],
"confidence": 0.9999401867389679,
"pixel": 898.0,
"text": "0.00",
"value": 0.0
}
]
}
追加一条审查结论
选择“有效 KM”时,四边 ROI、四个坐标范围、Panel、终点和曲线数均为必填。
追加式审计历史
最新事件仅作为当前缓存;以下每一条既往结论都永久保留。
| 事件 | 时间 / 审查人 | 状态 | ROI | 坐标 | 说明 |
|---|---|---|---|---|---|
| #41p1-visual-axis-audit-v2 · frozen benchmark contact sheets + original images + RapidOCR re-audit | 2026-07-28T15:12:18+00:00Codex-assisted visual audit | valid_km | {'x0': 552, 'x1': 1871, 'y0': 177, 'y1': 899} |
X 0.0–78.0 / Y 0.0–1.0 |
P1 冻结原图审查;人工检查冻结原图刻度;ROI 四边按可见坐标轴框记录。 |
最近一次正式比较
Suite #3 · 2026-07-28T15:15:12+00:00
真值完整 117 / 120;通过 0;缺真值 0;无效案例 3。



